인공 혈관 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 용도별, 지역별, 경쟁별(2020-2030년)
Vascular Graft Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region and Competition, 2020-2030F
상품코드:1728170
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 인공 혈관 시장은 2024년 12억 9,000만 달러로 예측 기간 동안 CAGR 7.31%로 성장하여 2030년까지 19억 7,000만 달러에 달할 것으로 예상됩니다.
이 시장은 주로 말초동맥질환(PAD), 동맥류, 관상동맥질환(CAD) 등 혈관질환의 유병률 증가로 인해 강력한 성장세를 보이고 있습니다. 혈관의 협착이나 막힘을 동반하는 이러한 질환은 뇌졸중, 심근경색, 사지 허혈과 같은 심각한 합병증을 유발할 수 있으며, 인공 혈관을 이용한 외과적 개입이 필요합니다. 또한, 관상동맥 우회술(CABG)이나 혈관내 동맥류 치료(EVAR)와 같은 시술이 증가하고 있는 것도 수요를 더욱 촉진하고 있습니다. 인공 혈관은 손상된 혈관을 대체하거나 우회하여 이러한 수술에서 중요한 역할을 하고 있습니다. 기술 발전과 제품 혁신도 시장을 발전시키고 있습니다. 예를 들어, 2022년 5월 UC Davis는 캘리포니아 재생의학연구소(California Institute for Regenerative Medicine)로부터 혈액투석 환자를 위한 차세대 인공 혈관을 개발하기 위해 300만 달러의 보조금을 받았습니다. 이러한 개발은 이식편의 성능과 수명 향상에 대한 이해관계자들의 지속적인 노력을 반영하는 것으로, 향후 몇 년 동안 시장 개척에 큰 도움이 될 것으로 기대됩니다.
Becton, Dickinson and Company(Bard Peripheral Vascular Inc.)
Cardinal Health(Cordis Corporation)
Cook Medical
Endologix Inc.
Getinge Group
LeMaitre Vascular Inc.
Medtronic PLC
Terumo Medical Corporation.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Vascular Graft Market was valued at USD 1.29 Billion in 2024 and is anticipated to reach USD 1.97 Billion by 2030, growing at a CAGR of 7.31% during the forecast period. The market is witnessing strong growth, primarily due to the increasing prevalence of vascular disorders such as peripheral artery disease (PAD), aneurysms, and coronary artery disease (CAD). These conditions, which involve the narrowing or blockage of blood vessels, can lead to critical complications like stroke, myocardial infarction, and limb ischemia, thereby necessitating surgical interventions using vascular grafts. Additionally, the rising volume of procedures such as coronary artery bypass grafting (CABG) and endovascular aneurysm repair (EVAR) has further supported demand. Vascular grafts play a crucial role in these surgeries by replacing or bypassing damaged blood vessels. Technological progress and product innovation are also advancing the market. For example, in May 2022, UC Davis received a USD 3 million grant from the California Institute for Regenerative Medicine to develop a next-generation vascular graft for hemodialysis patients. Such developments reflect the ongoing commitment of stakeholders to enhance the performance and longevity of grafts, which is expected to significantly boost market growth in the coming years.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.29 Billion
Market Size 2030
USD 1.97 Billion
CAGR 2025-2030
7.31%
Fastest Growing Segment
Coronary Artery By-pass Graft
Largest Market
North America
Key Market Drivers
Increasing Prevalence of Cardiovascular Diseases
The global vascular graft market is primarily driven by the escalating incidence of cardiovascular conditions such as coronary artery disease, peripheral arterial disease, and aortic aneurysms. These diseases represent a growing health concern worldwide, largely attributed to sedentary lifestyles, unhealthy diets, and an aging population. As more individuals develop comorbidities like hypertension, diabetes, and obesity, the risk of cardiovascular events increases, fueling the need for surgical interventions involving vascular grafts. This surge in disease burden directly correlates with rising demand for procedures like CABG and EVAR, where vascular grafts are essential for restoring adequate blood flow. As a result, the demand for graft-based solutions is set to grow steadily, supporting overall market expansion.
Key Market Challenges
Stringent Regulatory Hurdles
A significant challenge in the vascular graft market lies in the rigorous regulatory landscape governing medical devices. Organizations such as the U.S. FDA and EMA mandate thorough evaluations to ensure the safety and efficacy of vascular grafts, including extensive clinical trials and quality testing. While such standards are crucial for safeguarding public health, they contribute to extended development timelines and higher compliance costs. This can be particularly burdensome for smaller firms with limited resources, ultimately restricting the pace of innovation and delaying patient access to new products. Additionally, the need to navigate varying regulatory frameworks across different countries complicates global product approvals and increases market entry barriers for manufacturers.
Key Market Trends
Technological Advancements
Continuous innovation in graft materials and design is a key trend shaping the vascular graft market. Advanced materials, such as bioengineered and tissue-engineered grafts, have significantly enhanced the safety and performance of these products by improving biocompatibility and reducing the risk of complications. Furthermore, grafts featuring anti-thrombogenic and anti-infective coatings are gaining traction, offering better outcomes in terms of long-term patency and infection prevention. These developments not only improve surgical success rates but also enable wider application of vascular grafts in complex procedures. As technologies evolve, next-generation grafts are expected to play a more prominent role in vascular surgeries, encouraging wider clinical adoption and contributing to market growth.
Key Market Players
Abbott Laboratories
Braun Melsungen AG
Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
Cardinal Health (Cordis Corporation)
Cook Medical
Endologix Inc.
Getinge Group
LeMaitre Vascular Inc.
Medtronic PLC
Terumo Medical Corporation
Report Scope:
In this report, the Global Vascular Graft Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market.
Available Customizations:
Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
